BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15362874)

  • 1. Substrate-dependent modulation of the mechanism of factor XIa inhibition.
    Pedicord DL; Seiffert D; Blat Y
    Biochemistry; 2004 Sep; 43(37):11883-8. PubMed ID: 15362874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosite-mediated substrate recognition of factor IX by factor XIa. The factor XIa heavy chain is required for initial recognition of factor IX.
    Ogawa T; Verhamme IM; Sun MF; Bock PE; Gailani D
    J Biol Chem; 2005 Jun; 280(25):23523-30. PubMed ID: 15829482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macromolecular substrate-binding exosites on both the heavy and light chains of factor XIa mediate the formation of the Michaelis complex required for factor IX-activation.
    Sinha D; Marcinkiewicz M; Navaneetham D; Walsh PN
    Biochemistry; 2007 Aug; 46(34):9830-9. PubMed ID: 17676929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor IX activation by factor XIa proceeds without release of a free intermediate.
    Wolberg AS; Morris DP; Stafford DW
    Biochemistry; 1997 Apr; 36(14):4074-9. PubMed ID: 9100000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a factor IX binding site on the third apple domain of activated factor XI.
    Sun Y; Gailani D
    J Biol Chem; 1996 Nov; 271(46):29023-8. PubMed ID: 8910554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of factor IX by factor XIa--a spectrophotometric assay for factor IX in human plasma.
    Tans G; Janssen-Claessen T; van Dieijen G; Hemker HC; Rosing J
    Thromb Haemost; 1982 Oct; 48(2):127-32. PubMed ID: 6983739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor IX of the blood coagulation system: a review.
    Taran LD
    Biochemistry (Mosc); 1997 Jul; 62(7):685-93. PubMed ID: 9331959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modification of factor XIa functional activity upon binding to polyanions.
    Sinha D; Badellino KO; Marcinkiewicz M; Walsh PN
    Biochemistry; 2004 Jun; 43(23):7593-600. PubMed ID: 15182201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation.
    Smith SB; Verhamme IM; Sun MF; Bock PE; Gailani D
    J Biol Chem; 2008 Mar; 283(11):6696-705. PubMed ID: 18192270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage and inactivation of Factor IX by granulocyte elastase.
    Takaki A; Enfield DL; Thompson AR
    J Clin Invest; 1983 Nov; 72(5):1706-15. PubMed ID: 6605369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity.
    Rezaie AR; Sun MF; Gailani D
    Biochemistry; 2006 Aug; 45(31):9427-33. PubMed ID: 16878977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and chemical synthesis of a substrate-binding site for factor IX on coagulation factor XIa.
    Baglia FA; Jameson BA; Walsh PN
    J Biol Chem; 1991 Dec; 266(35):24190-7. PubMed ID: 1748688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Arg-4 mutant factor IX Strasbourg 2 shows a delayed activation by factor XIa.
    de la Salle C; Charmantier JL; Ravanat C; Ohlmann P; Hartmann ML; Schuhler S; Bischoff R; Ebel C; Roecklin D; Balland A
    Nouv Rev Fr Hematol (1978); 1993; 35(5):473-80. PubMed ID: 8295821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro mutagenesis study of two critical glutamic acids in the calcium binding loop of the factor IX heavy chain.
    Hamaguchi N; Stafford D
    Thromb Haemost; 1994 Dec; 72(6):856-61. PubMed ID: 7740454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
    Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
    Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A low molecular weight platelet inhibitor of factor XIa: purification, characterization, and possible role in blood coagulation.
    Cronlund AL; Walsh PN
    Biochemistry; 1992 Feb; 31(6):1685-94. PubMed ID: 1737024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX.
    Walsh PN; Bradford H; Sinha D; Piperno JR; Tuszynski GP
    J Clin Invest; 1984 May; 73(5):1392-9. PubMed ID: 6609171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional role of residue 193 (chymotrypsin numbering) in serine proteases: influence of side chain length and beta-branching on the catalytic activity of blood coagulation factor XIa.
    Schmidt AE; Sun MF; Ogawa T; Bajaj SP; Gailani D
    Biochemistry; 2008 Feb; 47(5):1326-35. PubMed ID: 18186617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Productive recognition of factor IX by factor XIa exosites requires disulfide linkage between heavy and light chains of factor XIa.
    Marcinkiewicz MM; Sinha D; Walsh PN
    J Biol Chem; 2012 Feb; 287(9):6187-95. PubMed ID: 22207756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.